PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III was reported 18 times

PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED STAGE III is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 LOMUSTINE 5 0.0019
1 CHLORAMBUCIL 5 0.0013
2 ETOPOSIDE 5 0.0001
3 DOXORUBICIN 5 0.0001
4 PREDNISOLONE ORAL SOLUTION 7 0.0000
5 CYCLOPHOSPHAMIDE FOR INJECTION 6 0.0000
6 CYCLOPHOSPHAMIDE 6 0.0000
7 RITUXIMAB 6 0.0000
8 ADALIMUMAB-FKJP 1 0.0000
9 ADALIMUMAB-AATY 1 0.0000
10 FERROUS SULFATE 1 0.0000
11 ADALIMUMAB-ADAZ 1 0.0000
12 METHOTREXATE SODIUM 8 0.0000
13 INSULIN ASPART 1 0.0000
14 TACROLIMUS OINTMENT 0.1% 1 0.0000
15 TACROLIMUS EXTENDED-RELEASE CAPSULES 1 0.0000
16 INSULIN LISPRO 1 0.0000
17 TACROLIMUS 1 0.0000
18 RANITIDINE 1 0.0000
19 ATORVASTATIN CALCIUM 1 0.0000
20 SIMVASTATIN 1 0.0000
21 AMLODIPINE 1 0.0000
22 ADALIMUMAB 2 0.0000
23 FUROSEMIDE 1 0.0000
24 PREDNISONE 1 0.0000